An organic heterotricyclic compound that consists of a triazole ring ortho-fused at any position to a quinazoline ring system.
ChEBI ID: 131355
| Member | Definition | Role |
|---|---|---|
| cgs 15943 | A member of the class of triazoloquinazolines that is [1,2,4]triazolo[1,5-c]quinazoline substited at positions 2, 5 and 9 by furan-2-yl, amino and chloro groups respectively. A potent antagonist at adenosine A1 and adenosine A2A receptors. | 9-chloro-2-(2-furanyl)-[1,2,4]triazolo[1,5-c]quinazolin-5-amine; CGS 15943 |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (2.92) | 18.7374 |
| 1990's | 62 (45.26) | 18.2507 |
| 2000's | 39 (28.47) | 29.6817 |
| 2010's | 22 (16.06) | 24.3611 |
| 2020's | 10 (7.30) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 4 (2.88%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 135 (97.12%) | 84.16% |